Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q90961867 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241221010744.0 | ||
| 008 | 241221nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q90961867 | ||
| 024 | ‡a 0000-0002-7073-4697 ‡2 orcid | ||
| 035 | ‡a (OCoLC)Q90961867 | ||
| 100 | 0 | ‡a Michelle Ferraz Oliveira Miranda ‡c researcher (ORCID 0000-0002-7073-4697) ‡9 en | |
| 400 | 0 | ‡a Michelle Ferraz Oliveira Miranda ‡c onderzoeker ‡9 nl | |
| 670 | ‡a Author's Hepatic changes after treatment with oxaliplatin | ||
| 909 | ‡a (orcid) 0000000270734697 ‡9 1 | ||
| 919 | ‡a hepaticchangesaftertreatmentwithoxaliplatin ‡A Hepatic changes after treatment with oxaliplatin ‡9 1 | ||
| 996 | ‡2 LC|n 86060289 | ||
| 996 | ‡2 BLBNB|001580821 | ||
| 996 | ‡2 RERO|A003598097 | ||
| 996 | ‡2 ISNI|0000000393248744 | ||
| 996 | ‡2 ISNI|0000000385582945 | ||
| 996 | ‡2 SUDOC|256945225 | ||
| 996 | ‡2 ISNI|0000000080011447 | ||
| 996 | ‡2 DNB|1056379928 | ||
| 996 | ‡2 LC|n 2002043323 | ||
| 996 | ‡2 NUKAT|n 2015148643 | ||
| 996 | ‡2 NTA|069249407 | ||
| 996 | ‡2 NTA|162882890 | ||
| 996 | ‡2 ISNI|0000000454251673 | ||
| 996 | ‡2 LC|no2016027198 | ||
| 996 | ‡2 BIBSYS|90364507 | ||
| 996 | ‡2 BLBNB|000553607 | ||
| 996 | ‡2 NTA|212778919 | ||
| 996 | ‡2 NSK|000210746 | ||
| 996 | ‡2 CAOONL|ncf11059253 | ||
| 996 | ‡2 SUDOC|095242031 | ||
| 996 | ‡2 LC|n 2024250196 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
